PCN81 Economic Evaluation of First-LINE Atezolizumab for Extensive-STAGE SMALL-Cell LUNG Cancer: The Difference between the Standard Parametric MODEL and the Mixture Cure MODEL
Abstract
Authors
M. Rui Y. Wang L. Yang X.T. Wang Y. Shang A.X. Ma H.C. Li